CDEK
← All organizations

Paragon Biomedical

For profit

Also known as: PARAGON BIOTECK

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

May 1, 2008

First marketed drug

Mar 21, 2013

Last known activity

Jan 1, 2011

Acquired by Clinipace LTD on Sep 25, 2012

Timeline

1980s

  1. Jan 1, 1989

    Paragon Biomedical— Founded

2010s

  1. Sep 25, 2012

    Clinipace LTD— Acquired By

  2. Mar 21, 2013

    phenylephrine— NDA Secondary Org

Drugs by trial phase (3 distinct, 3 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (3)

Details

Founded
Irvine, CA, US Jan 1, 1989
Last known activity
Jan 1, 2011